- Home
- DAWN vs GEL Comparison
DAWN vs GEL Comparison
Compare DAWN & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DAWN | GEL |
|---|---|---|
| Founded | 2018 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.1B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DAWN | GEL |
|---|---|---|
| Price | $21.50 | $16.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $24.43 | $19.50 |
| AVG Volume (30 Days) | ★ 1.4M | 240.2K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $158,182,000.00 | ★ $2,912,770,000.00 |
| Revenue This Year | $55.03 | $12.12 |
| Revenue Next Year | $28.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 20.60 | ★ 43.60 |
| 52 Week Low | $5.64 | $13.21 |
| 52 Week High | $21.53 | $18.64 |
Technical Indicators
Market Signals| Indicator | DAWN | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 80.29 | 44.20 |
| Support Level | $10.30 | $16.28 |
| Resistance Level | N/A | $17.01 |
| Average True Range (ATR) | 0.03 | 0.45 |
| MACD | -0.28 | 0.01 |
| Stochastic Oscillator | 90.91 | 40.00 |
Price Performance
Historical ComparisonAbout DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
About GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.